Orthofix appoints Wayne Burris to Board of Directors

Orthofix Medical Inc.

Wayne C. Burris appointed to Board effective Sept 22, 2021; serves on Audit & Finance Committee.
Burris was SVP and CFO at Roche Diagnostics until 2019; over 35 years in diagnostics, pharma, orthopedics.
Granted options to acquire 22,184 common shares vesting in 1/4 increments over four years.
Board expanded from seven to eight directors; Burris is independent under Nasdaq rules.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Wayne C. Burris

Director

OFIX · Orthofix Medical Inc.

Effective: 2021-09-22
Filed: September 23, 2021, 7:59 PM ET

Effective as of September 22, 2021, the Board of Directors (the “ Board ”) of Orthofix Medical Inc. (the “ Company ”), consistent with a recommendation made by the Board’s Nominating and Governance Committee, has appointed Wayne C. Burris as a director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wayne C. Burris was appointed as Director at Orthofix Medical Inc..

Action: appointed
Role: Director

Exact text from the filing

Effective as of September 22, 2021, the Board of Directors (the “ Board ”) of Orthofix Medical Inc. (the “ Company ”), consistent with a recommendation made by the Board’s Nominating and Governance Committee, has appointed Wayne C. Burris as a director.

View on SEC.gov

Orthofix Medical Inc. filing history →

Source: SEC EDGAR

accession 0001564590-21-048661

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.